Drucker Wealth 3.0 LLC Sells 45 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Drucker Wealth 3.0 LLC lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,084 shares of the healthcare conglomerate’s stock after selling 45 shares during the period. Drucker Wealth 3.0 LLC’s holdings in UnitedHealth Group were worth $1,054,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth about $26,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth about $28,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth about $30,000. Finally, Aster Capital Management DIFC Ltd acquired a new stake in UnitedHealth Group in the 4th quarter worth about $30,000. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on UNH. Mizuho dropped their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. JPMorgan Chase & Co. dropped their price objective on shares of UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating for the company in a research note on Thursday, May 15th. KeyCorp dropped their price objective on shares of UnitedHealth Group from $575.00 to $450.00 and set an “overweight” rating for the company in a research note on Wednesday, May 14th. Barclays dropped their price objective on shares of UnitedHealth Group from $513.00 to $362.00 and set an “overweight” rating for the company in a research note on Thursday, May 15th. Finally, Wall Street Zen lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $441.87.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Kristen Gil bought 3,700 shares of UnitedHealth Group stock in a transaction on Thursday, May 15th. The shares were purchased at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the acquisition, the director now directly owns 3,818 shares of the company’s stock, valued at $1,035,327.06. The trade was a 3,135.59% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the company’s stock in a transaction dated Friday, May 16th. The stock was purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the transaction, the chief executive officer now directly owns 679,493 shares in the company, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 109,408 shares of company stock valued at $31,607,768 in the last ninety days. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Trading Down 0.4%

Shares of UnitedHealth Group stock opened at $295.37 on Friday. The firm has a market capitalization of $267.94 billion, a PE ratio of 19.06, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm’s 50 day moving average is $452.40 and its 200 day moving average is $505.07. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period last year, the firm posted $6.91 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 2.84%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is 35.18%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.